Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1990;68(6):721–730.

Metrifonate in the control of urinary schistosomiasis in Zanzibar.

A F Mgeni 1, U M Kisumku 1, F S McCullough 1, H Dixon 1, S S Yoon 1, K E Mott 1
PMCID: PMC2393165  PMID: 2127381

Abstract

Selective population chemotherapy using three doses of metrifonate (7.5 mg/kg body weight each time) at two-week intervals was assessed in an entire community in Kinyasini district in Zanzibar, United Republic of Tanzania. The objectives of the study were to (1) reduce the prevalence of heavy infections (defined as greater than or equal to 50 S. haematobium eggs per 10 ml of urine) by 75% in two years, and (2) reduce the overall prevalence of infection by 50% in two years. A total of 4113 people were examined at least once during the two-year period. In the initial survey the highest proportion of infected individuals was in the 10-14-year age group, and in all subsequent surveys in the 5-9-year age group. The age group with the highest proportion of heavily infected individuals was 5-9 years for all surveys. The overall reduction of prevalence of infection from survey 1 to survey 4 was 52.9% and the prevalence of heavy infection was reduced by 62.2%. The conversion rates (negative to positive in two consecutive surveys) were highest in the longest interval of 12 months and the rates of reversion (positive to negative in two consecutive surveys, without a history of treatment) were highest in the shortest interval of 4 months. Some statistically significant relationships were observed between the number of doses and the egg reduction rates. However, for the egg-negative rates, no statistically significant relationship was observed. In the 4-month interval a 67.6% egg-negative rate was observed among those who took at least one dose; with the 12-month interval a 48.3% egg-negative rate was observed. Thus, selective population chemotherapy with metrifonate was shown to reduce the prevalence and intensity of infection due to S. haematobium over a 24-month period.

Full text

PDF
721

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Davis A., Bailey D. R. Metrifonate in urinary schistosomiasis. Bull World Health Organ. 1969;41(2):209–224. [PMC free article] [PubMed] [Google Scholar]
  2. Diallo S., Ceccon J. F., Victorius A., Diouf F., N'dir O. Efficacité de 3 cures de Métrifonate dans le traitement de la bilharziose urinaire au Sénégal. Dakar Med. 1983;28(1):67–76. [PubMed] [Google Scholar]
  3. Feldmeier H., Doehring E. Clinical experience with metrifonate. Review with emphasis on its use in endemic areas. Acta Trop. 1987 Sep;44(3):357–368. [PubMed] [Google Scholar]
  4. Forsyth D. M., Rashid C. Treatment of urinary schistosomiasis with trichlorophone. Lancet. 1967 Oct 28;2(7522):909–912. doi: 10.1016/s0140-6736(67)90230-9. [DOI] [PubMed] [Google Scholar]
  5. Forsyth D. M., Rashid C. Treatment of urinary schistosomiasis. Practice and theory. Lancet. 1967 Jan 21;1(7482):130–133. doi: 10.1016/s0140-6736(67)91034-3. [DOI] [PubMed] [Google Scholar]
  6. King C. H., Lombardi G., Lombardi C., Greenblatt R., Hodder S., Kinyanjui H., Ouma J., Odiambo O., Bryan P. J., Muruka J. Chemotherapy-based control of schistosomiasis haematobia. I. Metrifonate versus praziquantel in control of intensity and prevalence of infection. Am J Trop Med Hyg. 1988 Sep;39(3):295–305. doi: 10.4269/ajtmh.1988.39.295. [DOI] [PubMed] [Google Scholar]
  7. Korte R., Schmidt-Ehry B., Kielmann A. A., Brinkmann U. K. Cost and effectiveness of different approaches to schistosomiasis control in Africa. Trop Med Parasitol. 1986 Jun;37(2):149–152. [PubMed] [Google Scholar]
  8. Pugh R. N., Teesdale C. H. Long-term efficacy of single-dose oral treatment in schistosomiasis haematobium. Trans R Soc Trop Med Hyg. 1984;78(1):55–59. doi: 10.1016/0035-9203(84)90172-x. [DOI] [PubMed] [Google Scholar]
  9. Rugemalila J. B., Eyakuze V. M. Use of metrifonate for selective population chemotherapy against urinary schistosomiasis in an endemic area at Mwanza, Tanzania. East Afr Med J. 1981 Jan;58(1):37–43. [PubMed] [Google Scholar]
  10. Sato K., Shimada M., Noda S., Muhoho N. D., Katsumata T., Sato A., Aoki Y. Efficacy of metrifonate in a highly endemic area of urinary schistosomiasis in Kenya. Am J Trop Med Hyg. 1988 Jan;38(1):81–85. doi: 10.4269/ajtmh.1988.38.81. [DOI] [PubMed] [Google Scholar]
  11. Tswana S. A., Mason P. R. Eighteen-month follow-up on the treatment of urinary schistosomiasis with a single dose of metrifonate. Am J Trop Med Hyg. 1985 Jul;34(4):746–749. doi: 10.4269/ajtmh.1985.34.746. [DOI] [PubMed] [Google Scholar]
  12. el Kholy A., Boutros S., Tamara F., Warren K. S., Mahmoud A. A. The effect of a single dose of metrifonate on Schistosoma haematobium infection in Egyptian school children. Am J Trop Med Hyg. 1984 Nov;33(6):1170–1172. doi: 10.4269/ajtmh.1984.33.1170. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES